Your browser doesn't support javascript.
loading
Platinum-based chemotherapy plus cetuximab first-line for Asian patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: Results of an open-label, single-arm, multicenter trial.
Guo, Ye; Shi, Mei; Yang, Ankui; Feng, Jifeng; Zhu, Xiaodong; Choi, Young-Jin; Hu, Guoqin; Pan, Jianji; Hu, Chunhong; Luo, Rongcheng; Zhang, Yiping; Zhou, Liang; Cheng, Ying; Lüpfert, Christian; Cai, Junliang; Shi, Yuankai.
Afiliación
  • Guo Y; Medical Oncology Department, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Shi M; Radiation Oncology Department, Xijing Hospital - The First Affiliated Hospital of the Fourth Military Medical University, Shanxi Province, China.
  • Yang A; Head and Neck Department, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Feng J; Medical Oncology Department, Jiangsu Cancer Hospital, Nanjing, Jiangsu Province, China.
  • Zhu X; Radiotherapy Department, Affiliated Cancer Hospital, Guangxi Medical University, Nanning, Guangxi Province, China.
  • Choi YJ; Medical Oncology Department, Pusan National University Hospital, Seo-Gu, Busan, Korea.
  • Hu G; Cancer Department, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.
  • Pan J; Department of Radiation Oncology, Fujian Provincial Cancer Hospital, Fuzhou, China.
  • Hu C; Oncology Department, The Second Xiangya Hospital of Central South University, Changsha, Hu'nan Province, China.
  • Luo R; Cancer Medical Department, Nanfang Hospital, Guangzhou, China.
  • Zhang Y; Chemotherapy Center, Zhejiang Cancer Hospital, Hangzhou, Zhejiang Province, China.
  • Zhou L; Head and Neck Surgery Department, Eye and Ear, Nose, and Throat Hospital of Fudan University, Xuhui District, Shanghai, China.
  • Cheng Y; Medical Oncology Department, Jilin Cancer Hospital, Changchun, Jilin, China.
  • Lüpfert C; Merck KGaA, Darmstadt, Germany.
  • Cai J; Merck Serono (Beijing) Pharmaceutical R&D Company, The Center, Shanghai, China.
  • Shi Y; Department of Medical Oncology, Cancer Institute/Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Chaoyang District, Beijing, China.
Head Neck ; 37(8): 1081-7, 2015 Aug.
Article en En | MEDLINE | ID: mdl-24710768
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Escamosas / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de Cabeza y Cuello / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Head Neck Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Escamosas / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de Cabeza y Cuello / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Head Neck Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article País de afiliación: China